Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Leading Cardiovascular Physicians and Researchers Present New Science in Heart Failure Prevention

The Academy's Biochemical Pharmacology Discussion Group and the New York Chapter of the American Chemical Society host a Translational Medicine symposium.

Published September 15, 2010

Heart failure, along with sudden cardiac death, is a leading cause of mortality in the U.S. Development of effective therapies has been hampered by a lack of understanding of the mechanisms that cause these disorders. A September 28 symposium at the New York Academy of Sciences, “Targeted Molecular Therapy for Preventing Heart Failure and Sudden Cardiac Death,” will review the biology and current therapeutic approaches for treating sudden cardiac death, and discuss current research efforts to identify useful molecular targets and practical therapeutic approaches to combat this disease. Speakers will also review current clinical treatments, and discuss new approaches to address this unmet medical need.

WHAT: A Scientific Symposium: Targeted Molecular Therapy for Preventing Heart Failure and Sudden Cardiac Death

WHO: Speakers:
Fadi G. Akar, PhD, Assistant Professor of Medicine, Mt. Sinai School of Medicine, and adjunct Assistant Professor, Division of Cardiology and Computational Medicine, Johns Hopkins University

Roger J. Hajjar, MD, Director of the Cardiovascular Research Institute, and Arthur & Janet C. Ross Professor of Medicine at Mount Sinai School of Medicine

Mariell Jessup, MD, Professor of Medicine, University of Pennsylvania School of Medicine, Associate Chief - Clinical Affairs, Cardiovascular Division of Medicine and Medical Director, Heart and Vascular Center at Penn Medicine

Walter J. Koch, PhD, W. W. Smith Professor of Medicine, Director, Center for Translational Medicine, and Vice Chair for Research, Department of Medicine, Thomas Jefferson University

Evangelia (Litsa) Kranias, PhD, Distinguished University Research Professor, Hanna Professor of Cardiology, Chair, Department of Pharmacology and Cell Biophysics, and co-Director of the Cardiovascular Center of Excellence, University of Cincinnati College of Medicine

WHEN: Tuesday, September 28, 2010 | 1:00 pm – 5:00 pm

WHERE: The New York Academy of Sciences
7 World Trade Center, 250 Greenwich St., 40th floor, New York, NY

This symposium is presented by the New York Academy of Sciences' Biochemical Pharmacology Discussion Group and the New York Chapter of the American Chemical Society, and is part of the Academy’s Translational Medicine Initiative, sponsored by the Josiah Macy Jr. Foundation. For more information see Media must register in advance by contacting Adrienne Burke, Director, Public Outreach, the New York Academy of Sciences, at, 212.298.8655.